# Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater Trochanteric Pain Syndrome

> **NCT02031367** · EARLY_PHASE1 · UNKNOWN · sponsor: **C.R.Darnall Army Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Greater Trochanteric Pain Syndrome

## Interventions

- **DRUG:** Triamcinolone Acetonide
- **OTHER:** Platelet Rich Plasma

## Key facts

- **NCT ID:** NCT02031367
- **Lead sponsor:** C.R.Darnall Army Medical Center
- **Sponsor class:** FED
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2014-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02031367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02031367, "Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater Trochanteric Pain Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02031367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*